Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium
- PMID: 11440132
- DOI: 10.1271/bbb.65.1163
Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium
Abstract
Fusobacterium K-60, a ginsenoside Rb1-metabolizing bacterium, was isolated from human intestinal feces. From this Fusodobacterium K-60, a ginsenoside Rb1-metabolizing enzyme, beta-glucosidase, has been purified. The enzyme was purified to apparent homogeneity by a combination of butyl-Toyopearl, hydroxyapatite ultragel, Q-Sepharose, and Sephacryl S-300 HR column chromatographies with a final specific activity of 1.52 micromol/min/mg. It had optimal activity at pH 7.0 and 40 degrees C. The molecular mass of this purified enzyme was 320 kDa, with 4 identical subunits (80 kDa). The purified enzyme activity was inhibited by Ba++, Fe++, and some agents that modify cysteine residues. This enzyme strongly hydrolyzed sophorose, followed by p-nitrophenyl beta-D-glucopyranoside, esculin, and ginsenoside Rb1. However, this enzyme did not change 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol (IH-901) to 20(S)-protopanaxadiol, while it weakly changed ginsenoside Rb1 to IH-901. These findings suggest that the Fusobacterial beta-glucosidase is a novel enzyme transforming ginsenoside Rb1.
Similar articles
-
Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria.Biol Pharm Bull. 2000 Dec;23(12):1481-5. doi: 10.1248/bpb.23.1481. Biol Pharm Bull. 2000. PMID: 11145182
-
Purification method improvement and characterization of a novel ginsenoside-hydrolyzing beta-glucosidase from Paecilomyces Bainier sp. 229.Biosci Biotechnol Biochem. 2008 Feb;72(2):352-9. doi: 10.1271/bbb.70425. Epub 2008 Feb 7. Biosci Biotechnol Biochem. 2008. PMID: 18256474
-
Purification and characterization of ginsenoside Ra-hydrolyzing beta-D-xylosidase from Bifidobacterium breve K-110, a human intestinal anaerobic bacterium.Biol Pharm Bull. 2003 Aug;26(8):1170-3. doi: 10.1248/bpb.26.1170. Biol Pharm Bull. 2003. PMID: 12913270
-
Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing β-D-glucosidase from Bifidobacterium longum H-1.Biol Pharm Bull. 2012;35(4):573-81. doi: 10.1248/bpb.35.573. Biol Pharm Bull. 2012. PMID: 22466563
-
Progress in the Conversion of Ginsenoside Rb1 into Minor Ginsenosides Using β-Glucosidases.Foods. 2023 Jan 13;12(2):397. doi: 10.3390/foods12020397. Foods. 2023. PMID: 36673490 Free PMC article. Review.
Cited by
-
Compound K Production: Achievements and Perspectives.Life (Basel). 2023 Jul 14;13(7):1565. doi: 10.3390/life13071565. Life (Basel). 2023. PMID: 37511939 Free PMC article. Review.
-
Biochemical and Structural Analysis of a Glucose-Tolerant β-Glucosidase from the Hemicellulose-Degrading Thermoanaerobacterium saccharolyticum.Molecules. 2022 Jan 4;27(1):290. doi: 10.3390/molecules27010290. Molecules. 2022. PMID: 35011521 Free PMC article.
-
Application of microorganisms in Panax ginseng: cultivation of plants, and biotransformation and bioactivity of key component ginsenosides.Arch Microbiol. 2024 Oct 16;206(11):433. doi: 10.1007/s00203-024-04144-8. Arch Microbiol. 2024. PMID: 39412649 Review.
-
Bioconversion of ginsenoside rb1 into compound k by Leuconostoc citreum LH1 isolated from kimchi.Braz J Microbiol. 2011 Jul;42(3):1227-37. doi: 10.1590/S1517-838220110003000049. Epub 2011 Sep 1. Braz J Microbiol. 2011. PMID: 24031746 Free PMC article.
-
Gut microbiota-mediated pharmacokinetics of ginseng saponins.J Ginseng Res. 2018 Jul;42(3):255-263. doi: 10.1016/j.jgr.2017.04.011. Epub 2017 Apr 28. J Ginseng Res. 2018. PMID: 29983606 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous